Gene: RGL3
Official Full Name: ral guanine nucleotide dissociation stimulator like 3provided by HGNC
Gene Summary: Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in Ras protein signal transduction. Predicted to be located in cytosol. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14577 | RGL3 Knockout cell line (HeLa) | Human | RGL3 | 1:3~1:6 | Negative | Online Inquiry |
KO14578 | RGL3 Knockout cell line (HCT 116) | Human | RGL3 | 1:2~1:4 | Negative | Online Inquiry |
KO14579 | RGL3 Knockout cell line (A549) | Human | RGL3 | 1:3~1:4 | Negative | Online Inquiry |
RGL3 Gene Knockout Cell Lines are an innovative biological tool designed to facilitate research studies involving the RGL3 gene, which is implicated in various cellular processes such as growth regulation, apoptosis, and signal transduction pathways. By utilizing the technologies of CRISPR/Cas9 gene editing, RGL3 Gene Knockout Cell Lines provide researchers with a cellular model where the RGL3 gene function has been selectively disrupted, allowing for detailed investigation of its biological roles.
The key function of these cell lines lies in their ability to serve as robust models for studying gene-environment interactions, drug responses, and the mechanistic basis of diseases associated with aberrant RGL3 activity. By understanding how the absence of RGL3 affects cellular behavior, researchers can glean insights into fundamental biological processes, paving the way for potential therapeutic strategies.
In the context of research and clinical settings, RGL3 Gene Knockout Cell Lines hold scientific importance as they can be harnessed for high-throughput drug screening, functional genomics, and target validation studies. Their application extends to the exploration of cancer biology, neurological disorders, and metabolic diseases, making them versatile tools across multiple research domains.
Compared to conventional cell lines, RGL3 Gene Knockout Cell Lines offer distinct advantages such as specificity in gene editing and stability in gene expression. This high degree of control over genetic modifications enhances reproducibility and robustness of experimental results, which are critical parameters in scientific research.
For researchers and clinicians, the value of RGL3 Gene Knockout Cell Lines is underscored by their potential to accelerate discoveries in gene function and disease mechanisms, ultimately contributing to the development of innovative therapeutic approaches. With a commitment to advancing biological research, our company specializes in providing high-quality genetic models that empower scientists to tackle the challenges in understanding complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.